top of page
Search

SKIA Wins CES 2024 Innovation Award for AR Education Solution

  • Writer: 효석 이
    효석 이
  • May 13, 2024
  • 1 min read

Updated: May 9

SKIA Wins CES 2024 Innovation Award for AR Education Solution


SKIA announced on the 21st that it has been selected as a recipient of the CES 2024 Innovation Award, one of the highest honors at the world’s largest consumer electronics show, CES. This year, only eight companies worldwide were recognized for their innovations in the virtual and augmented reality (VR/AR) category.


SKIA is the first company globally to develop a markerless AR surgical platform for medical use. For CES 2024, the company showcased SKIA_OPD, an AR-based solution that helps educate patients about pathological conditions, surgical procedures, and recovery progress. The solution is currently available in both South Korea and India, providing valuable support in helping patients and their families better understand the progression of diseases and the treatment processes before surgery or therapy.


Lee Jong-myeong, CEO of SKIA, expressed his gratitude, saying, "We are thrilled to have our technology recognized globally. We will continue to innovate, creating safer surgical environments for doctors and providing patients with reliable medical information through augmented reality."


In addition, SKIA recently participated in Expand North Star 2023, a major startup expo held in Dubai in October. The company won the healthcare category in the Supernova Challenge, a high-profile startup pitching contest.





Source: Electronic Times, Reporter Song Hye-young, November 21, 2023

 
 
 

Recent Posts

See All

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
SKIA LOGO WHITE

Solutions

Company

Contact

EMAIL
LINKEDIN
YOUTUBE

SKIA Head, Breast, and Forensics solutions are under development and not commercially available at this time. 

 

​​SKIA Face and Body are currently approved in South Korea, and SKIA OPD is available for sale. Media shown on this website are actual patient cases, but all personal identities have been removed or otherwise anonymized.

SKIA Head and Breast are not yet cleared by the FDA and are not available for sale. Any information about the device, including its potential benefits and risks, is based on preliminary data and should be interpreted accordingly. These devices are not intended for diagnosing, treating, or preventing medical conditions without the supervision of a qualified healthcare professional. SKIA does not guarantee the accuracy or completeness of the information provided and is not liable for any damages arising from the use of the devices or reliance on the information.

©2025 SKIA Inc.

Copyright © 2024 SKIA

bottom of page